Skip to content

Clinical trials

Observational Nephrosis, Lipoid trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Nephrosis, Lipoid Phase: Observational Country / region: United States Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20101
20191
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting3
Active, not recruiting1
Completed1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Michigan3
Beth Israel Deaconess Medical Center1
Goldfinch Bio, Inc.1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glomerulosclerosis, Focal Segmental6
Nephrosis, Lipoid6
Kidney Diseases3
Nephrotic Syndrome3
Diabetic Nephropathies2
Glomerulonephritis, Membranous2
Proteinuria2
Disease1
Edema1
Kidney Failure, Chronic1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.